Ben Mead
Impact in
- Ophthalmology top 1%
- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
- Genetics top 2%
- Mesenchymal stem cell research
Papers in
-
- Retinal Development and Disorders 11
- Extracellular vesicles in disease 9
- Pluripotent Stem Cells Research 4
-
- Glaucoma and retinal disorders 5
- Co-authors
- Stanislav I. Tomarev (12 shared papers)Martin Berry (10 shared papers)Ann Logan (10 shared papers)Wendy Leadbeater (9 shared papers)Ben A. Scheven (7 shared papers)Zubair Ahmed (6 shared papers)Juan Amaral (1 shared paper)Robert A. H. Scott (2 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (6 papers)Experimental Eye Research (2 papers)PLoS ONE (2 papers)Stem Cells (2 papers)Stem Cells Translational Medicine (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Ben Mead
38 papers receiving 2.1k citations
Ben Mead's Hit Papers
Peers
Comparison fields: 5 of 85
- Ophthalmology 417
- Genetics 477
- Developmental Neuroscience 121
- Cancer Research 267
- Cellular and Molecular Neuroscience 327
Countries citing papers authored by Ben Mead
This map shows the geographic impact of Ben Mead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Mead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Mead more than expected).
Fields of papers citing papers by Ben Mead
This network shows the impact of papers produced by Ben Mead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Mead. The network helps show where Ben Mead may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Mead, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms Hit paper breakdown → | 2017 | 366 |
| 2 | 2014 | 198 | |
| 3 | 2015 | 180 | |
| 4 | 2013 | 177 | |
| 5 | 2018 | 120 | |
| 6 | 2016 | 112 | |
| 7 | 2020 | 111 | |
| 8 | 2018 | 99 | |
| 9 | 2016 | 97 | |
| 10 | 2016 | 84 | |
| 11 | 2017 | 68 | |
| 12 | 2020 | 64 | |
| 13 | 2014 | 53 | |
| 14 | 2015 | 51 | |
| 15 | 2017 | 39 | |
| 16 | 2015 | 39 | |
| 17 | 2018 | 31 | |
| 18 | 2014 | 22 | |
| 19 | 2020 | 21 | |
| 20 | 2018 | 21 |
About Ben Mead
Ben Mead is a scholar working on Molecular Biology, Ophthalmology, Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Genetics, having authored 39 papers that have together received 2.1k indexed citations. Recurring topics across this work include Retinal Development and Disorders (11 papers), Extracellular vesicles in disease (9 papers), Corneal Surgery and Treatments (8 papers), Glaucoma and retinal disorders (5 papers), Nerve injury and regeneration (5 papers), Pluripotent Stem Cells Research (4 papers), Mesenchymal stem cell research (4 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Ophthalmology (417 citations), Genetics (477 citations), Developmental Neuroscience (121 citations), Cancer Research (267 citations) and Cellular and Molecular Neuroscience (327 citations). Ben Mead has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Stanislav I. Tomarev, Martin Berry, Ann Logan, Wendy Leadbeater, Ben A. Scheven, Zubair Ahmed, Juan Amaral, Robert A. H. Scott, Lisa J. Hill and Richard J. Blanch. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Experimental Eye Research, PLoS ONE, Stem Cells and Stem Cells Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.